Could This Report Be The Definitive Answer To Your Xarelto Lawsuit?

Our attorneys - http://Www.Wood-Furniture.biz/search/search.php?query=attorneys&search=1 have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto ( rivaroxaban drug class - http://homecomfortservice.ca/node/60745 ) and suffered critical bleeding events. Pharmaceutical firms, like the makers of Xarelto, possess a duty to ensure that their drugs are reasonably protected for use - and failure to complete so may be grounds for compensation. Our lawyers are operating tough to get these hurt by the drug the compensation they may be entitled to.

Whilst bleeding can be a typical complication related with anticoagulants, it has been alleged that Xarelto is more unsafe than classic blood thinners because no antidote exists to reverse its blood-thinning effects. This means that, inside the occasion of an emergency, patients may possibly be at risk for irreversible bleeding troubles, like life-threatening internal and gastrointestinal hemorrhaging.

In case you or a loved one suffered a serious bleeding occasion after taking Xarelto, you may have legal recourse. For far more info, get in touch with us today to possess your case reviewed, cost-free of charge.

Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are searching for compensation - http://Www.broowaha.com/search/compensation from Bayer and Janssen for previous and future medical bills, lost wages, pain and suffering and, in instances of death, funeral expenses. Furthermore, they're looking for punitive damages, which are typically awarded to punish the defendant and deter other organizations from acting similarly.

Why Are Lawsuits Being Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding inside the occasion of an emergency. Plaintiffs in the lawsuits allege serious and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.

The makers of the drug continue to market Xarelto as a protected anticoagulant option.

Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user in the event of a bleeding complication.

Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.

Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing unsafe clotting.

Visit this page for more information on the alleged health risks of Xarelto.

Multidistrict Litigation Trial Dates Set

The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.